Hepatitis B carriers are not hepatitis. Hepatitis B carriers indicate that the body is in the immune tolerance period, the presence of the hepatitis B virus in the body, but normal liver function, no obvious symptoms, while hepatitis is generally more indicated as the active stage of the disease, accompanied by clinical symptoms. Hepatitis B carriers and hepatitis are two concepts, but they can be converted and influenced by each other under certain circumstances. Hepatitis B carriers are patients who have been infected with the hepatitis B virus in their bodies, and after treatment, the hepatitis B virus is still present in their bodies, but their liver function is normal, and they do not have changes of liver fibrosis and cirrhosis. Hepatitis B carriers usually do not have clinical symptoms, such as nausea, vomiting, discomfort in the liver area, etc. This stage of the patient does not mean that there is no contagious, but only relative to the active hepatitis patients, the contagiousness is slightly reduced. Hepatitis usually indicates that the patient’s condition is in the active stage, the quantitative amount of hepatitis B virus in the body is high, and the liver function has obvious abnormalities, such as an increase in alanine aminotransferase and an increase in azalea aminotransferase, etc. The patient’s blood biochemistry examination shows that the liver function is not infectious. In addition to abnormalities in blood biochemical tests, hepatitis patients will also experience nausea, vomiting, generalized fatigue and other uncomfortable symptoms. In daily life, for hepatitis B virus carriers, it is recommended to review liver function, blood routine and biochemistry every 6 to 12 months, and follow the doctor’s instructions for treatment.